Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KATNA1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | DDX60L | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | LTB | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | LGALS4 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | MLLT11 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | ASB18 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | FAM19A2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | MBP | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | ATP5H | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | FADS3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |